2015
DOI: 10.1016/j.contraception.2015.06.135
|View full text |Cite
|
Sign up to set email alerts
|

Contraceptive access in Canada compared with access in other countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Despite clinical guidance that women with HIV may safely use all contraceptive options, the range of methods used in this cohort is more limited than that used by women in the general Canadian population, particularly with respect to the low prevalence of hormonal and long‐acting reversible contraceptives (use of hormonal methods is estimated at 44% in the general population) . The limited range of methods reported may be a result of health system or provider barriers, including lingering questions about the safety of hormonal contraceptives for women with HIV. Systematic reviews reporting that hormonal methods do not accelerate HIV disease progression are reassuring; however, robust data are needed to clarify whether they increase HIV transmissibility and whether certain antiretroviral regimens compromise their effectiveness (and vice versa) .…”
Section: Discussionmentioning
confidence: 96%
“…Despite clinical guidance that women with HIV may safely use all contraceptive options, the range of methods used in this cohort is more limited than that used by women in the general Canadian population, particularly with respect to the low prevalence of hormonal and long‐acting reversible contraceptives (use of hormonal methods is estimated at 44% in the general population) . The limited range of methods reported may be a result of health system or provider barriers, including lingering questions about the safety of hormonal contraceptives for women with HIV. Systematic reviews reporting that hormonal methods do not accelerate HIV disease progression are reassuring; however, robust data are needed to clarify whether they increase HIV transmissibility and whether certain antiretroviral regimens compromise their effectiveness (and vice versa) .…”
Section: Discussionmentioning
confidence: 96%